QUELMIA Trademark

Trademark Overview


On Thursday, August 13, 2015, a trademark application was filed for QUELMIA with the United States Patent and Trademark Office. The USPTO has given the QUELMIA trademark a serial number of 86724536. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 21, 2019. This trademark is owned by Actavis, Inc. The QUELMIA trademark is filed in the Pharmaceutical Products category with the following description:

Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to sensory organs; Pharmaceuticals and medi...
quelmia

General Information


Serial Number86724536
Word MarkQUELMIA
Filing DateThursday, August 13, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 21, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 23, 2016

Trademark Statements


Goods and ServicesOral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to sensory organs; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to the central nervous system; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to urogenital organs; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 19, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameALLERGAN FINANCE, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressPARSIPPANY, NJ 07054

Party NameActavis, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Party NameActavis, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Tuesday, January 22, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 21, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, January 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 18, 2019EXTENSION 4 GRANTED
Friday, April 13, 2018EXTENSION 4 FILED
Saturday, October 20, 2018RESPONSE TO ITU OFFICE ACTION ENTERED
Friday, January 18, 2019REVIEW OF CORRESPONDENCE COMPLETE
Saturday, October 20, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, September 4, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 10, 2018ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
Friday, April 13, 2018TEAS EXTENSION RECEIVED
Wednesday, January 3, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, October 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 5, 2017EXTENSION 3 GRANTED
Thursday, October 5, 2017EXTENSION 3 FILED
Thursday, October 5, 2017TEAS EXTENSION RECEIVED
Thursday, March 30, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 29, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 29, 2017EXTENSION 2 GRANTED
Wednesday, March 22, 2017EXTENSION 2 FILED
Wednesday, March 29, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 22, 2017TEAS EXTENSION RECEIVED
Monday, January 30, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 10, 2016EXTENSION 1 GRANTED
Monday, October 10, 2016EXTENSION 1 FILED
Monday, October 10, 2016TEAS EXTENSION RECEIVED
Tuesday, April 19, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 23, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 23, 2016PUBLISHED FOR OPPOSITION
Wednesday, February 3, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 2, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 2, 2015EXAMINER'S AMENDMENT ENTERED
Wednesday, December 2, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 2, 2015EXAMINERS AMENDMENT E-MAILED
Wednesday, December 2, 2015EXAMINERS AMENDMENT -WRITTEN
Friday, November 27, 2015ASSIGNED TO EXAMINER
Wednesday, August 19, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 17, 2015NEW APPLICATION ENTERED IN TRAM